Arch Therapeutics Inc
OTC:ARTH
Arch Therapeutics Inc
OTC:ARTH
Price:
0.0001
USD
Market Closed
Market Cap:
$444
Relative Value
There is not enough data to reliably calculate the relative value of ARTH.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ARTH
Relative Value
Base Case
Not Available
Multiples Across Competitors
ARTH Competitors Multiples
Arch Therapeutics Inc Competitors
Arch Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Arch Therapeutics Inc
OTC:ARTH
|
444.4 USD | 0 | -0 | 0 | 0 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
65.4B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.2 | 37.2 | 26.5 | 31.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
31.6B CHF | 4 | 39.3 | 16.2 | 31.5 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
108.4B DKK | 3.9 | 27.2 | 14.2 | 16.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.1B USD | 3.2 | 31.8 | 16.9 | 22 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.3B USD | 1.2 | -17.5 | 18 | 58.3 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP | 2.8 | 29.9 | 13.2 | 21.5 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.9B CNY | 9 | 24.8 | 22.3 | 22.3 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
790.8B JPY | 6.1 | 44.7 | 21 | 28.5 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
3.8B CHF | 4.8 | 19.3 | 12.6 | 17.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
